| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLNO | Common Stock | Sale | $132,942 | -2,817 | -3% | $47.19 | 92,461 | 28 Aug 2024 | Direct | F1, F2, F3 |
| transaction | SLNO | Common Stock | Sale | $117,811 | -2,453 | -2.7% | $48.03 | 90,008 | 28 Aug 2024 | Direct | F1, F3, F4 |
| transaction | SLNO | Common Stock | Sale | $208,728 | -4,426 | -4.9% | $47.16 | 85,582 | 29 Aug 2024 | Direct | F1, F3, F5 |
| transaction | SLNO | Common Stock | Sale | $48,263 | -1,009 | -1.2% | $47.83 | 84,573 | 29 Aug 2024 | Direct | F1, F3, F6 |
| Id | Content |
|---|---|
| F1 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
| F2 | This transaction was executed in multiple trades at prices ranging from $46.81 to $47.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F3 | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
| F4 | This transaction was executed in multiple trades at prices ranging from $47.81 to $48.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F5 | This transaction was executed in multiple trades at prices ranging from $46.73 to $47.725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F6 | This transaction was executed in multiple trades at prices ranging from $47.735 to $48.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Officer title: Senior Vice President, Clinical Operations